<DOC>
	<DOCNO>NCT01676740</DOCNO>
	<brief_summary>To establish efficacy screen anemia treatment mild anemia iron vitamins prior THR TKR mean increase hemoglobin reduce perioperative allogeneic blood transfusion .</brief_summary>
	<brief_title>Iron Vitamin Adminstration Prior Joint Replacement Prevent Transfusion</brief_title>
	<detailed_description>Patients mild anemia identify preoperative clinic visit - Patients screened inclusion exclusion criterion - Eligible patient laboratory test perform follow : CBC , liver kidney function test , serum iron , transferrin , ferritin , serum folic acid , vitamin B12 C-reactive protein - Patients assigned deficient group non-deficient group depend upon laboratory hematinic value - Patients `` non-deficient ' group randomize use computer-generated code treatment treatment - Treatment begin within 2 week laboratory test 4-6 week prior surgery . - Hematinic therapy consist oral ferric hydrochloride polymaltose 200 mg/d folic acid 0.4 mg/d ; sublingual vitamin B12 1000 µg three time week - On day surgery laboratory test perform follow : CBC , kidney liver function test , serum iron , transferrin , ferritin , serum folic acid , vitamin B12 C-reactive protein . - The surgical team center operate study patient blind preoperative hemoglobin - Routine postoperative management provide determined treat physician - Blood transfusion decide upon study physician center blind patient ' group assignment preoperative hemoglobin - The primary outcome perioperative blood transfusion ( 24 hour prior surgery hospital discharge ) - Secondary outcome length hospitalization , postoperative wound infection , walk ability across room 30 day</detailed_description>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Hematinics</mesh_term>
	<criteria>Age &gt; 50 year Ability provide inform consent Elective THR TKR Mild anemia : Hematocrit 2939 % men , 2936 % woman Identified cause anemia exclude hematinic deficiency Known source blood loss Known coagulopathy Unstable coronary syndrome previous 3 month Pathologic fracture , presence malignancy Repeat THR TKR Orthopedic trauma within previous 3 month ASA class ≥ 4 Creatinine clearance &lt; 30 ml/min AST/ALT &gt; 2x upper limit normal Preexisting use hematinic agent Planned acute normovolemic hemodilution Refusal receive blood product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>hematinic therapy</keyword>
	<keyword>blood transfusion</keyword>
	<keyword>joint replacement</keyword>
</DOC>